MiR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages

Biochemical and Biophysical Research Communications

Volumn 448, Issue 3, 2014, Pages 329-334

  Zhao, Ranzun ^a   Feng, Jian ^a   He, Guoxiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ABCA1; Cholesterol efflux; LXR ; MicroRNA 613; PPAR

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; LIVER X RECEPTOR ALPHA; MICRORNA; MICRORNA 613; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WESTERN BLOTTING;

ABCA1; CHOLESTEROL EFFLUX; LXRΑ; MICRORNA-613; PPARΓ;

3' UNTRANSLATED REGIONS; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; BASE SEQUENCE; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CHOLESTEROL; DOWN-REGULATION; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICRORNAS; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84901376901     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.052     Document Type: Article

References (33)

1. T.A. Gaziano Cardiovascular disease in the developing world and its cost-effective management Circulation 112 2005 3547 3553 (Pubitemid 43739531)
2. C.K. Glass, and J.L. Witztum Atherosclerosis. The road ahead Cell 104 2001 503 516
3. M. Cuchel, and D.J. Rader Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113 2006 2548 2555 (Pubitemid 43948034)
4. R.L. Tiwari, V. Singh, and M.K. Barthwal Macrophages: an elusive yet emerging therapeutic target of atherosclerosis Med. Res. Rev. 28 2008 483 544 (Pubitemid 351842141)
5. Y. Yuan, P. Li, and J. Ye Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis Protein Cell 3 2012 173 181
6. A. Majdalawieh, and H.S. Ro PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 Nucl. Recept. Signal. 8 2010 e004
7. S.Z. Duan, M.G. Usher, and R.M. Mortensen Peroxisome proliferator- activated receptor-gamma-mediated effects in the vasculature Circ. Res. 102 2008 283 294 (Pubitemid 351271648)
8. A.C. Li, and C.K. Glass PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis J. Lipid Res. 45 2004 2161 2173 (Pubitemid 39602963)
9. X. Xu, Q. Li, L. Pang, G. Huang, J. Huang, M. Shi, X. Sun, and Y. Wang Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-gamma/LXR-alpha signaling pathway Biochem. Biophys. Res. Commun. 441 2013 321 326
10. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtiss, R.M. Evans, and P. Tontonoz A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol. Cell 7 2001 161 171 (Pubitemid 32162909)
11. X. Wang, H.L. Collins, M. Ranalletta, I.V. Fuki, J.T. Billheimer, G.H. Rothblat, A.R. Tall, and D.J. Rader Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo J. Clin. Invest. 117 2007 2216 2224 (Pubitemid 47219566)
12. A. Venkateswaran, B.A. Laffitte, S.B. Joseph, P.A. Mak, D.C. Wilpitz, P.A. Edwards, and P. Tontonoz Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha Proc. Natl. Acad. Sci. USA 97 2000 12097 12102
13. M. Bodzioch, E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W.E. Kaminski, H.W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K.J. Lackner, and G. Schmitz The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease Nat. Genet. 22 1999 347 351 (Pubitemid 29369524)
14. L. He, and G.J. Hannon MicroRNAs: small RNAs with a big role in gene regulation Nat. Rev. Genet. 5 2004 522 531 (Pubitemid 38868508)
15. C. Fernandez-Hernando, C.M. Ramirez, L. Goedeke, and Y. Suarez MicroRNAs in metabolic disease Arterioscler. Thromb. Vasc. Biol. 33 2013 178 185
16. R. Schickel, B. Boyerinas, S.M. Park, and M.E. Peter MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Oncogene 27 2008 5959 5974
17. K.C. Vickers, K.A. Rye, and F. Tabet MicroRNAs in the onset and development of cardiovascular disease Clin. Sci. (Lond.) 126 2014 183 194
18. M. Kawai, and C.J. Rosen PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis Nat. Rev. Endocrinol. 6 2010 629 636
19. R. Simo, A. Rodriguez, and E. Caveda Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone Curr. Drug Saf. 5 2010 234 244
20. D.S. Straus, and C.K. Glass Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms Trends Immunol. 28 2007 551 558 (Pubitemid 350101420)
21. M. Viladomiu, R. Hontecillas, L. Yuan, P. Lu, and J. Bassaganya-Riera Nutritional protective mechanisms against gut inflammation J. Nutr. Biochem. 24 2013 929 939
22. J. Bar-Tana Peroxisome proliferator-activated receptor gamma (PPARgamma) activation and its consequences in humans Toxicol. Lett. 120 2001 9 19 (Pubitemid 32375067)
23. A. Davalos, L. Goedeke, P. Smibert, C.M. Ramirez, N.P. Warrier, U. Andreo, D. Cirera-Salinas, K. Rayner, U. Suresh, J.C. Pastor-Pareja, E. Esplugues, E.A. Fisher, L.O. Penalva, K.J. Moore, Y. Suarez, E.C. Lai, and C. Fernandez-Hernando MiR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling Proc. Natl. Acad. Sci. USA 108 2011 9232 9237
24. C. Esau, S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, M. Pear, L. Watts, S.L. Booten, M. Graham, R. McKay, A. Subramaniam, S. Propp, B.A. Lollo, S. Freier, C.F. Bennett, S. Bhanot, and B.P. Monia MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab. 3 2006 87 98
25. D. Iliopoulos, K. Drosatos, Y. Hiyama, I.J. Goldberg, and V.I. Zannis MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism J. Lipid Res. 51 2010 1513 1523
26. * in adipocyte gene expression and lipogenesis Am. J. Physiol. Endocrinol. Metab. 299 2010 E198 E206
27. D. Zhong, G. Huang, Y. Zhang, Y. Zeng, Z. Xu, Y. Zhao, X. He, and F. He MicroRNA-1 and microRNA-206 suppress LXRalpha-induced lipogenesis in hepatocytes Cell. Signal. 25 2013 1429 1437
28. Q. Lin, Z. Gao, R.M. Alarcon, J. Ye, and Z. Yun A role of miR-27 in the regulation of adipogenesis FEBS J. 276 2009 2348 2358
29. Z. Yang, Z. Yuan, Y. Fan, X. Deng, and Q. Zheng Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma Mol. Med. Rep. 8 2013 1353 1358
30. R. Anton, S.S. Chatterjee, J. Simundza, P. Cowin, and R. Dasgupta A systematic screen for micro-RNAs regulating the canonical Wnt pathway PLoS One 6 2011 e26257
31. D. Zhong, Y. Zhang, Y.J. Zeng, M. Gao, G.Z. Wu, C.J. Hu, G. Huang, and F.T. He MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRalpha Lipids Health Dis. 12 2013 32
32. D. Ye, B. Lammers, Y. Zhao, I. Meurs, T.J. Van Berkel, and M. Van Eck ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis Curr. Drug Targets 12 2011 647 660
33. M. Xu, H. Zhou, K.C. Tan, R. Guo, S.W. Shiu, and Y. Wong ABCG1 mediated oxidized LDL-derived oxysterol efflux from macrophages Biochem. Biophys. Res. Commun. 390 2009 1349 1354